You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tofacitinib

Showing 26 - 50 of 258
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier

Completed
  • Arthritis Rheumatoid
  • Tofacitinib
  • New York, New York
    Pfizer
Jun 8, 2022

Adherence Of Tofacitinib of Ulcerative Colitis In Clinical

Recruiting
  • Ulcerative Colitis
  • tofacitinib
  • Alingsås, Sweden
  • +12 more
Nov 17, 2022

Systemic Lupus Erythematosus, Cutaneous Lupus Trial in Ann Arbor (Tofacitinib)

Recruiting
  • Systemic Lupus Erythematosus
  • Cutaneous Lupus
  • Tofacitinib
  • Ann Arbor, Michigan
    University of Michigan Health System: Department of Internal Med
May 2, 2022

Immune-Mediated Colitis Trial in Montreal (Tofacitinib 10 mg)

Recruiting
  • Immune-Mediated Colitis
  • Tofacitinib 10 mg
  • Montreal, Quebec, Canada
    Sir Mortimer B Davis Jewish General Hospital - CIUSSS Centre-Oue
May 11, 2022

Sarcoidosis, Pulmonary, Sarcoidosis Lung, Sarcoidosis Trial in Portland (drug, diagnostic test, genetic)

Completed
Has Results
  • Sarcoidosis, Pulmonary
  • +2 more
  • Tofacitinib 5mg Oral Tablet [Xeljanz] 16 week trial
  • +5 more
  • Portland, Oregon
    Oregon Health & Science University
Dec 3, 2021

Alopecia Areata Trial in Bangkok (Tofacitinib)

Completed
Has Results
  • Alopecia Areata
  • Tofacitinib
  • Bangkok, Thailand
    Institute of Dermatology
Mar 28, 2022

Rheumatoid Arthritis, Interstitial Lung Disease Trial in Mexico City (Tofacitinib)

Recruiting
  • Rheumatoid Arthritis
  • Interstitial Lung Disease
  • Tofacitinib
  • Mexico City, Tlalpan, Mexico
    Instituto Nacional de Enfermedades Respiratorias, Ismael Cosío V
Apr 4, 2022

Vitiligo, Effect of Drug Trial (JAK-2 inhibitor, Topical corticosteroid)

Not yet recruiting
  • Vitiligo
  • Effect of Drug
  • JAK-2 inhibitor
  • Topical corticosteroid
  • (no location specified)
Mar 19, 2022

Ulcerative Colitis, Thromboembolism Trial in Madrid (Tofacitinib, Infliximab Adalimumab y Golimumab)

Recruiting
  • Ulcerative Colitis
  • Thromboembolism
  • Tofacitinib
  • Infliximab Adalimumab y Golimumab
  • Madrid, Spain
    Hospital Universitario de La Princesa
Aug 2, 2022

COVID-19 Pneumonia Trial in New Haven (Tofacitinib 10 mg, Placebo)

Terminated
  • COVID-19 Pneumonia
  • Tofacitinib 10 mg
  • Placebo
  • New Haven, Connecticut
    Yale New Haven Health System
Mar 16, 2022

Primary Sjögren's Syndrome Trial in Beijing (Tofacitinib)

Recruiting
  • Primary Sjögren's Syndrome
  • Tofacitinib
  • Beijing, Beijing, China
    Department of Rheumatology and Immunology, Peking University Peo
Feb 28, 2022

TofAcitinib in Routine Care Rheumatoid Arthritis- Cardiovascular

Completed
  • Rheumatoid Arthritis
  • Tofacitinib
  • TNF Inhibitor
  • Boston, Massachusetts
    Brigham And Women's Hospital
Mar 1, 2022

Patterns And Effect Of Tofacitinib Indicators For Rheumatoid

Completed
  • Arthritis, Rheumatoid
    • New York, New York
      Pfizer
    Jun 8, 2022

    That Distinguish Between Tofacitinib Responders and

    Completed
    • Ulcerative Colitis
    • GWAS analysis by Illumina BeadChip
    • New York, New York
      New York University School of Medicine
    Aug 9, 2022

    Healthy Subjects Trial in Québec (Tofacitinib Citrate)

    Completed
    • Healthy Subjects
    • Tofacitinib Citrate
    • Québec, Canada
      Syneos Health Facility
    Nov 25, 2021

    Tofacitinib on Body Composition, Bone Mineral Density and Bone

    Suspended
    • Rheumatoid Arthritis
    • Tofacitinib
    • Lille, France
      Lille University Hospital
    Feb 7, 2022

    Generate Real World Data On Tofacitinib Induction Therapy and

    Recruiting
    • Ulcerative Colitis
    • Stool sample collection
    • Bern, Bern (de), Switzerland
    • +8 more
    Jan 25, 2023

    Down Syndrome, Regression Trial (Lorazepam, Intravenous immunoglobulin (IVIG), Tofacitinib)

    Not yet recruiting
    • Down Syndrome
    • Regression
    • (no location specified)
    Dec 14, 2022

    Tofacitinib PsA Initiators in the CorEvitas SpA Registry

    Active, not recruiting
    • Psoriatic Arthritis
      • New York, New York
        Pfizer
      Feb 8, 2022

      Discoid Lupus Erythematosus, Systemic Lupus Erythematosus Trial in Boston (Tofacitinib citrate)

      Terminated
      • Discoid Lupus Erythematosus
      • Systemic Lupus Erythematosus
      • Tofacitinib citrate
      • Boston, Massachusetts
        Tufts Medical Center
      Jan 6, 2022

      Ulcerative Colitis Trial in Chapel Hill

      Enrolling by invitation
      • Ulcerative Colitis
        • Chapel Hill, North Carolina
          Division of Gastroenterology and Hepatology
        Feb 21, 2022

        Rheumatoid Arthritis, Therapy Trial in Jinan (Iguratimod)

        Recruiting
        • Rheumatoid Arthritis
        • Therapy
        • Jinan, Shandong, China
          Yanfeng Hou
        Nov 24, 2023

        Tofatib Treatment for IgG4-related Disease

        Recruiting
        • IgG4-related Disease
        • tofacitinib
        • Shanghai, Shanghai, China
          Shanghai Changhai Hospital
        Nov 15, 2022

        Takayasu Arteritis Trial in Beijing (Adalimumab Injection, Tofacitinib 5 MG)

        Recruiting
        • Takayasu Arteritis
        • Adalimumab Injection
        • Tofacitinib 5 MG
        • Beijing, China
        • +3 more
        Feb 26, 2022

        Ulcerative Colitis Trial in Miami (Tofacitinib, Fast Mimicking Diet, Ustekinumab induction)

        Recruiting
        • Ulcerative Colitis
        • Tofacitinib
        • +3 more
        • Miami, Florida
        • +1 more
        Apr 22, 2022